OSCR News and Press, Oscar Health Inc. Class A

2026-02-16 21:04:00 ET It seems as though every industry outside of artificial intelligence (AI) is in the dumps. Even health insurance stocks had one of the wildest years in the sector's history in 2025. Why? Because of an unforeseen rise in healthcare costs from multiple sources, which cr...

2026-02-13 11:41:56 ET Post-earnings investment thesis Oscar Health ( OSCR ) is a health insurance company which leverages technology to enhance operational efficiency. While our investment thesis and conviction in the Company had been explained in previous analysis , the ke...

2026-02-12 05:04:11 ET from Raymond James issued a price target of $18.00 for OSCR on 2026-02-12 09:37:57. The adjusted price target was set to $18.00. At the time of the announcement, OSCR was trading at $13.6. The overall price target consensus is at $15.40 with high p...

2026-02-12 04:15:04 ET Raymond James analyst issues OUTPERFORM recommendation for OSCR on February 12, 2026 09:37AM ET. OSCR was trading at $13.6 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 2 - Buy, ...

2026-02-11 11:14:48 ET Investment Overview Oscar Health, Inc. ( OSCR ), the New York-headquartered health insurance company, announced its Q4 and full-year 2025 earnings yesterday. I last covered the company in a note for Seeking Alpha back in November 2023 , issuing a B...

2026-02-11 09:09:32 ET In this video, I will cover Oscar Health 's (NYSE: OSCR) recent earnings report and call. Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock prices used were from the trading day of Feb. 10, 2026. Th...

2026-02-10 20:27:33 ET Unexpectedly optimistic guidance was the factor powering Oscar Health 's (NYSE: OSCR) rise on the stock market Tuesday. The next-generation healthcare company reported its latest set of financial results, and while it missed analyst estimates on trailing r...

2026-02-10 14:20:29 ET More on Oscar Health Oscar Health, Inc. (OSCR) Q4 2025 Earnings Call Transcript Oscar: An Overlooked 2026 Inflection Oscar Health: High Growth, High Acuity Create Investors' Dilemma Oscar Health expects $18.7B–$19B revenue in 202...

2026-02-10 13:17:04 ET More on Oscar Health Oscar Health, Inc. (OSCR) Q4 2025 Earnings Call Transcript Oscar: An Overlooked 2026 Inflection Oscar Health: High Growth, High Acuity Create Investors' Dilemma CVS Health, Centene, Elevance among insurers to receiv...

2026-02-10 13:14:29 ET Oscar Health, Inc. (OSCR) Q4 2025 Earnings Call February 10, 2026 8:00 AM EST Company Participants Chris Potochar - Vice President of Treasury & Investor Relations Mark Bertolini - CEO & Director Richard Blackley - Chief Financial Off...